CervoMed Inc. Increase (Decrease) in Deferred Revenue
CervoMed Inc. (CRVO) reported Increase (Decrease) in Deferred Revenue of $0 for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2025-08-08
- CervoMed Inc. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was -$1.40M.
- CervoMed Inc. increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was $829.03K, a 24.22% increase year-over-year.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month |
|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | ||
| 2024-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$572.48K derived: sum of 2 quarters · filed 2025-08-08 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $829.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.40M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $572.48K 10-Q · filed 2025-05-12 | ||
| 2023-09-30 | -$622.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $45.23K derived: sum of 2 quarters · filed 2024-11-12 | $547.05K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $667.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.17M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $501.82K 10-Q · filed 2024-05-14 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |